All Stories

The World Can’t Wait: Delivering on the Promise of Biopharma’s “Golden Age” Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca

BIO 2025 showed the science is ready—now it’s time to ensure access, equity, and impact for patients.

Jun 23, 2025 - 13:45
 0
The World Can’t Wait: Delivering on the Promise of Biopharma’s “Golden Age” Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca
BIO 2025 showed the science is ready—now it’s time to ensure access, equity, and impact for patients.
Read More

Tags:

Previous Article

Otsuka pens $670M pact to point Harbour's preclinical T-cell engager toward auto...

Next Article

Precision Matters: Elevating AI Excellence in MedTech and Pharma with WCG’s Avoc...

Related Posts

Prothena reburies drug after second swing at rare disease misses, plans ‘substantial’ layoffs

Prothena reburies drug after second swing at rare disea...

May 27, 2025  0

GSK offloads shigella vaccine to Bharat ahead of phase 3, vows to support fundraising

GSK offloads shigella vaccine to Bharat ahead of phase ...

Jun 12, 2025  0

Philips to test ultralow-dose X-ray technique in cath lab study

Philips to test ultralow-dose X-ray technique in cath l...

May 21, 2025  0